About The Condition
Understanding Diabetic Macular Edema
Diabetic macular edema (DME) is a common complication of diabetic retinopathy and a leading cause of vision loss in patients with diabetes.
It occurs when damaged blood vessels leak fluid into the macula, causing swelling and distortion of central vision.
Early detection and timely treatment are critical to preventing progression and maintaining visual function.
WHY EARLY REFERRAL MATTERS
Why Timely Referral for DME is Critical
DME can develop gradually but may lead to permanent vision loss if not treated appropriately. Delays in referral and treatment may affect a patient’s ability to read, drive, and perform daily tasks. Prompt referral may allow for:
- Early confirmation of diagnosis
- Immediate access to retinal imaging
- Timely initiation of treatment when indicated
Patients are assessed and managed within clinically appropriate timelines to help reduce the risk of vision loss.
SIGNS & SYMPTOMS
When to Refer A Patient
Consider referral for retinal assessment in patients with:
- Suspected or confirmed diabetic macular edema
- Reduced or fluctuating central vision
- OCT evidence of macular thickening or fluid
- Moderate to severe non-proliferative or proliferative diabetic retinopathy with macular involvement
- Difficulty assessing the macula due to media opacity or uncertain findings
- Persistent visual symptoms despite initial management
Patients with new or worsening visual symptoms may benefit from timely retinal evaluation to guide management.
Delivered through Precision Retina Care
Clinical Approach to DME
DME is typically managed through a clinical approach that may include advanced imaging, individualized treatment planning, and ongoing monitoring. Care includes:
- Comprehensive retinal evaluation
- High-resolution imaging (OCT and related technologies)
- Diagnosis confirmation and disease staging
- Ongoing monitoring and response assessment
Treatment often involves intravitreal anti-VEGF therapy, laser treatment and/or corticosteroid-based approaches, tailored to the patient’s condition and response over time.
RAPID ACCESS MODEL
Access to Assessment for DME
Dr. Varun Chaudhary provides clinical care through Precision Retina Care (PRC), with coordinated access for patients with time-sensitive retinal conditions such as DME.
- Referrals are triaged and scheduled promptly
- Patients are contacted directly for coordination
- Assessment and treatment are targeted within clinically appropriate timeframes
This model aims to support timely care to preserve vision and prevent disease progression.
Need Help or Want to Learn More?
Frequently Asked Questions About DME
What is the relationship between diabetes and DME?
DME is caused by damage to retinal blood vessels due to diabetes, leading to fluid leakage and swelling in the macula.
How quickly should a patient with suspected DME be referred?
Patients with visual symptoms or known diabetic retinopathy may benefit from timely referral for retinal evaluation, as earlier assessment and management can influence outcomes.
What happens after a referral is sent?
Referrals are reviewed and triaged, and patients are contacted directly to arrange assessment and retinal imaging based on clinical urgency.
What treatments are available for DME?
Treatment for DME may include intravitreal injections (such as anti-VEGF or corticosteroid therapies), along with monitoring and follow-up based on the patient’s conditions.
Will DME patients require ongoing care?
DME may require on-going monitoring and, in some cases, repeated treatments depending on disease activity.
Can patients participate in clinical trials?
Some patients may be eligible to participate in clinical trials evaluating emerging therapies. Availability depends on study criteria and enrolment.